Concepedia

Naohiro Kawaguchi

NK

Statistics

Publications

6

Citations

169

H-Index

6

Active since

2011

Affiliations

Takeda (Japan)(Current)

Naohiro Kawaguchi is an author at Takeda (Japan) specializing in pharmacology, drug disposition, and medicine.

Publications per year

2011–2016

6

Publications

6

<i>In vitro</i> metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker

Hitomi Yamasaki, Naohiro Kawaguchi, Masami Nonaka et al. · Xenobiotica · 2016 · 66 citations

, , +15

Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models

Keiji Kusumoto, Hideki Igata, Mami Ojima et al. · European Journal of Pharmacology · 2011 · 53 citations

, , +17

Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs

Akifumi Kogame, Toshiyuki Takeuchi, Masami Nonaka et al. · Xenobiotica · 2016 · 18 citations

, , +11

UDP-glucuronosyltransferase 2B15 (UGT2B15) Is the Major Enzyme Responsible for Sipoglitazar Glucuronidation in Humans: Retrospective Identification of the UGT Isoform by In Vitro Analysis and the Effect of UGT2B15*2 Mutation

Mitsuhiro Nishihara, Yuto Hiura, Naohiro Kawaguchi et al. · Drug Metabolism and Pharmacokinetics · 2013 · 11 citations

, , +13

An Unusual Metabolic Pathway of Sipoglitazar, a Novel Antidiabetic Agent: Cytochrome P450-Catalyzed Oxidation of Sipoglitazar Acyl Glucuronide

Mitsuhiro Nishihara, Miyako Sudo, Naohiro Kawaguchi et al. · Drug Metabolism and Disposition · 2011 · 11 citations

, , +15

1–5 of 6